Tadayoni R. Oculis OCS-01 phase 2 study results: A topical therapeutic for DME. Presented at: Euretina; Oct. 2-4, 2020 (virtual meeting).
VIDEO: First topical treatment for DME may lead to paradigm shift
At the virtual Euretina meeting, Ramin Tadayoni, MD, PhD, presents the results of the phase 2 study of OCS-01, the first topical treatment for diabetic macular edema.
Eye drops for DME are a long-awaited option and will be an interesting alternative treatment for patients in whom intravitreal injections are not suitable.